Volume 16, Number 12—December 2010
Research
Anatomy of Bluetongue virus Serotype 8 Epizootic Wave, France, 2007-2008
Table 1
Species | Department code | No. positive†/no. tested | Herd-level seroprevalence (95% CI‡) | No. outbreaks§ | Reporting rate¶ (95% CI) | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cattle | 08 | 63/63 | 1.00 (0.94–1.00) | 37 | 0.59 (0.46–0.71) | ||||||||||||||||||||||||||||||
18 | 49/49 | 1.00 (0.93–1.00) | 4 | 0.08 (0.02–0.20) | |||||||||||||||||||||||||||||||
41 | 42/50 | 0.84 (0.71–0.93) | 3 | 0.07 (0.01–0.19) | |||||||||||||||||||||||||||||||
36 | 29/48 | 0.60 (0.45–0.74) | 1 | 0.03 (0.00–0.18) | |||||||||||||||||||||||||||||||
37 | 31/50 | 0.62 (0.47–0.75) | 0 | 0.00 (0.00–0.11) | |||||||||||||||||||||||||||||||
49 | 1/50 | 0.02 (0.00–0.11) | 0 | 0.00 (0.00–0.98) | |||||||||||||||||||||||||||||||
|
35
|
2/50
|
0.04 (0.00–0.14)
|
0
|
0.00 (0.00–0.84)
| ||||||||||||||||||||||||||||||
Sheep | 08 | 42/44 | 0.95 (0.85–0.99) | 23 | 0.55 (0.39–0.70) | ||||||||||||||||||||||||||||||
18 | 14/59 | 0.24 (0.14–0.37) | 2 | 0.14 (0.02–0.43) | |||||||||||||||||||||||||||||||
36 | 0/4 | 0.00 (0.00–0.60) | NA | NA | |||||||||||||||||||||||||||||||
35 | 0/50 | 0.00 (0.00–0.07) | NA |
NA
|
*CI, confidence interval; NA, no seropositive flock. | |||||
†No. seropositive herds: >1positive result among tested serum samples. | |||||
‡Exact binomial 95% CI. | |||||
§No. seropositive herds with reported confirmed clinical disease in 2007. | |||||
¶Proportion of seropositive herds with reported confirmed clinical cases in 2007. |
Page created: August 28, 2011
Page updated: October 04, 2011
Page reviewed: October 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.